tirzepatide carlsbad Obesity drug seen as effective for long COVID, gets clinical trial Tirzepatide Protocol Training as Medical

Notably, most studies were published very recently (20242025), highlighting the novelty of this topic and the emerging nature of GLP-1 research in this context

Several large peer-reviewed studies have shown they can help people shed up to 15 per cent of their body weight, so doctors in Australia have started prescribing the medications "off-label", for use in weight loss

She also notes that oral semaglutide is expected to receive FDA approval for chronic weight management soon, broadening its availability for those seeking effective weight loss solutions without diabetes

According to a survey from Leger Healthcare, 8% of respondents are currently on a prescription GLP-1